Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

HOWARD S HOCHSTER

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1538160668
CMS profile
160773
Location
NEW HAVEN, CT

General Payments · PY2018–2024

$148,023.37

  • Reported across 118 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$56,490.06

24 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $46,071.50 7
Travel and Lodging $9,947.25 9
Food and Beverage $471.31 8

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $38,973.18 8
Tempus AI, Inc $6,939.60 4
Regeneron Pharmaceuticals, Inc. $6,630.17 9
BeiGene USA, Inc. $2,250.00 1
GlaxoSmithKline, LLC. $1,600.00 1
Genentech, Inc. $97.11 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $29,589.78 38
PY2019 $21,355.21 27
PY2020 $16,195.16 12
PY2021 $5,030.00 4
PY2022 $2,561.93 2
PY2023 $16,801.23 11
PY2024 $56,490.06 24

Payment records · PY2024 (24)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
BeiGene USA, Inc. $2,250.00 09/28/2024 Consulting Fee Undisputed 01/23/2026 1120867212 CMS
Genentech, Inc. $97.11 09/29/2024 Food and Beverage Undisputed 01/23/2026 1133021105 CMS
GlaxoSmithKline, LLC. $1,600.00 01/22/2024 Consulting Fee Undisputed 01/23/2026 1116708949 CMS
Regeneron Pharmaceuticals, Inc. $60.36 01/12/2024 Food and Beverage Undisputed 01/23/2026 1114400227 CMS
Regeneron Pharmaceuticals, Inc. $60.55 01/12/2024 Food and Beverage Undisputed 01/23/2026 1114400229 CMS
Regeneron Pharmaceuticals, Inc. $54.55 01/12/2024 Food and Beverage Undisputed 01/23/2026 1114400231 CMS
Regeneron Pharmaceuticals, Inc. $123.44 01/12/2024 Food and Beverage Undisputed 01/23/2026 1114400233 CMS
Regeneron Pharmaceuticals, Inc. $827.00 03/22/2024 Consulting Fee Undisputed 01/23/2026 1114400235 CMS
Regeneron Pharmaceuticals, Inc. $4,962.00 03/22/2024 Consulting Fee Undisputed 01/23/2026 1114400237 CMS
Regeneron Pharmaceuticals, Inc. $409.33 03/22/2024 Travel and Lodging Undisputed 01/23/2026 1114400239 CMS
Regeneron Pharmaceuticals, Inc. $85.00 03/22/2024 Travel and Lodging Undisputed 01/23/2026 1114400241 CMS
Regeneron Pharmaceuticals, Inc. $47.94 03/22/2024 Travel and Lodging Undisputed 01/23/2026 1114400243 CMS
Takeda Pharmaceuticals U.S.A., Inc. $9,937.50 08/30/2024 Consulting Fee Undisputed 01/23/2026 1144959154 CMS
Takeda Pharmaceuticals U.S.A., Inc. $473.77 08/30/2024 Travel and Lodging Undisputed 01/23/2026 1144959156 CMS
Takeda Pharmaceuticals U.S.A., Inc. $28.42 09/14/2024 Food and Beverage Undisputed 01/23/2026 1144959158 CMS
Takeda Pharmaceuticals U.S.A., Inc. $663.06 09/16/2024 Travel and Lodging Undisputed 01/23/2026 1144959160 CMS
Takeda Pharmaceuticals U.S.A., Inc. $7,073.70 10/02/2024 Travel and Lodging Undisputed 01/23/2026 1144959162 CMS
Takeda Pharmaceuticals U.S.A., Inc. $34.60 10/02/2024 Travel and Lodging Undisputed 01/23/2026 1144959164 CMS
Takeda Pharmaceuticals U.S.A., Inc. $19,995.00 11/02/2024 Consulting Fee Undisputed 01/23/2026 1144959166 CMS
Takeda Pharmaceuticals U.S.A., Inc. $767.13 11/04/2024 Travel and Lodging Undisputed 01/23/2026 1144959168 CMS
Tempus AI, Inc $15.04 01/19/2024 Food and Beverage Undisputed 01/23/2026 1150166356 CMS
Tempus AI, Inc $31.84 04/20/2024 Food and Beverage Undisputed 01/23/2026 1150166358 CMS
Tempus AI, Inc $392.72 05/14/2024 Travel and Lodging Undisputed 01/23/2026 1150259228 CMS
Tempus AI, Inc $6,500.00 05/14/2024 Consulting Fee Undisputed 01/23/2026 1150259234 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.